(Q38672214)

5 September 2017

title

Autophagy during cardiac remodeling (English)

1 reference

5 September 2017

0 references

Kazuhiko Nishida

1

1 reference

5 September 2017

Kinya Otsu

series ordinal

2

1 reference

5 September 2017

publication date

8 December 2015

1 reference

Journal of Molecular and Cellular Cardiology

5 September 2017

published in

1 reference

5 September 2017

volume

95

1 reference

5 September 2017

page(s)

11-18

1 reference

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Molecular mechanisms of myocardial remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy: an affair of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Alterations in mitochondrial function in cardiac hypertrophy and heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Reversal of cardiac hypertrophy by medical treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The autophagosome: origins unknown, biogenesis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The role of Atg proteins in autophagosome formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy: renovation of cells and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy in the Pathogenesis of Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy fights disease through cellular self-digestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Discovery of Atg5/Atg7-independent alternative macroautophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Ulk1-mediated Atg5-independent macroautophagy mediates elimination of mitochondria from embryonic reticulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Regulation of cardiac hypertrophy by intracellular signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Redox regulation of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Hypertension as a risk factor for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Left ventricular remodelling in aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The role of autophagy in the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Cardiac hypertrophy in rats after supravalvular aortic constriction. II. Inhibition of cellular autophagy in hypertrophying cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Cardiac hypertrophy in rats after supravalvular aortic constriction. I. Size and number of cardiomyocytes, endothelial and interstitial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Short-term inhibition of cardiac cellular autophagy by isoproterenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Rapamycin prevents thyroid hormone-induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Reverse remodeling in heart failure--mechanisms and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Left ventricular mass regression early after aortic valve replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Regression of cellular hypertrophy after left ventricular assist device support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Cardiac autophagy is a maladaptive response to hemodynamic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Cardiac autophagy: good with the bad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy and the integrated stress response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Markers of autophagy are downregulated in failing human heart after mechanical unloading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Lysosomal glycogen storage disease with normal acid maltase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Danon disease: focusing on heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Autophagy is an adaptive response in desmin-related cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Enhanced autophagy ameliorates cardiac proteinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The heart on fire: inflammasome and cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The Importance of NLRP3 Inflammasome in Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Translation of hemodynamic stress to sterile inflammation in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Pattern recognition receptors and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The role of autophagy emerging in postinfarction cardiac remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mammalian target of rapamycin signaling in cardiac physiology and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Response to Crozatier and Ventura-Clapier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mitochondrial membrane permeabilization in cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mending a broken heart: the role of mitophagy in cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mitochondrial therapeutics for cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Exercise and the cardiovascular system: clinical science and cardiovascular outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Basic mechanisms in heart failure: the cytokine hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Proinflammatory cytokines in heart failure: double-edged swords

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Degradation systems in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Crosstalk between autophagy and apoptosis in heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

The interplay between autophagy and apoptosis in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.003

10.1016/J.YJMCC.2015.12.003

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference